Risk Prevention Program for Adults With Uncontrolled Epilepsy
Tests a risk prevention session added to patient education in adults with uncontrolled epilepsy.
Plain-language title generated from the registry record
Registry title: Risk Prevention Program and Therapeutic Patient Education Program of Patients With Uncontrolled Epilepsy
Key facts
- Where
- Montpellier and Toulouse, FranceSee the 2 sites
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 60 years old?
Source: NCT06202196, who can take part
Where in France
- CHU Gui de ChauliacMontpellier, FranceTaking people
- CHU de ToulouseToulouse, FranceTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- University Hospital, Montpellier
- Trial code
- NCT06202196
- Record updated
- 13 July 2026
- Original description
Pilot, controled, randomized study aiming to evaluate a plan for the prevention of risks related to epilepsy, 3 months after the last therapeutic patient education session. Two groups of patients will be compared: group "intervention" (consultation with the neurologist then a psychologist followed by a session dedicated to risk prevention ("Recognize and Manage risks") integrated into usual Therapeutic Patient Education (TPE) versus "control" group (usual consultations with the neurologist and usual TPE).Read full original descriptionShow less
Evaluate the Impact of a Specific Risk Prevention Program Associated With a Therapeutic Patient Education Program on the Risk Behaviors of Adult Patients With Uncontrolled Epilepsy.
Pilot, controled, randomized study aiming to evaluate a plan for the prevention of risks related to epilepsy, 3 months after the last therapeutic patient education session. Two groups of patients will be compared: group "intervention" (consultation with the neurologist then a psychologist followed by a session dedicated to risk prevention ("Recognize and Manage risks") integrated into usual Therapeutic Patient Education (TPE) versus "control" group (usual consultations with the neurologist and usual TPE).
37 subjects per group will be included in this study.
Inclusion: Patient between 18 and 60 years old; Patient with poorly controlled epilepsy (persistence of seizures evolving for more than a year despite proper treatment) or patient seizure-free for over a year but for whom therapeutic patient education (TPE) would be beneficial according to the investigator; Patient agreeing to participate in a therapeutic education program (TPE).
Exclusion: Epileptic patient who has already benefited from a TPE epilepsy program; Patients with major cognitive impairment; Failure to obtain written informed consent after a reflection period; Patient under guardianship or legal protection (safeguard of justice); Pregnant or breast-feeding women; Patient who for geographical, social or psychological reasons could not participate in the research; Any situation that, in the opinion of the investigator, could present risks to the patient and to the research; Participation in another therapeutic research; Subjects not covered by public health insurance.